MiddleBrook Pharmaceuticals laid off 80 sales and nine corporate employees to contain costs, the company said in a regulatory filing. The move follows a round of job cuts announced by the biotech firm in September, when it eliminated corporate staff by 20% and its sales workforce by 25%.

Related Summaries